Showing results (11-20 of 59) with videos related to
Sort By:
Pageof 6
Neuroscience Letters|July 19, 1988
Intracerebral dopaminergic transplants are not activated by electrical footshock stress activating in situ mesocorticolimbic neuronsJ P Herman, J M Rivet, N Abrous, et al.Brain Research|June 21, 1988
Differential sensitization to amphetamine and stress responsivity as a function of inherent lateralityG J LaHoste, P Mormède, J M Rivet, et al.Brain Research|December 6, 1988
New evidence for distinct patterns of brain organization in rats differentiated on the basis of inherent lateralityG J LaHoste, P Mormède, J M Rivet, et al.Neuroendocrinology|October 1, 1989
Study of the influence of stress and adrenalectomy on central and peripheral neuropeptide Y levels. Comparison with catecholaminesJ M Rivet, V Castagné, R Corder, et al.Journal of Neurochemistry|December 31, 1997
Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving ratsA Gobert, J M Rivet, L Cistarelli, et al.Physiology & Behavior|August 1, 1992
Central and peripheral effects of repeated stress and high NaCl diet on neuropeptide YR Corder, V Castagné, J M Rivet, et al.Neuroscience|September 29, 1999
Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actionsA Gobert, J M Rivet, L Cistarelli, et al.Journal of Neurochemistry|May 1, 1996
Dopamine D3 (auto) receptors inhibit dopamine release in the frontal cortex of freely moving rats in vivoA Gobert, F Lejeune, J M Rivet, et al.Brain Research|September 3, 1990
Similar post-lesion receptor readjustments following the unilateral 6-hydroxydopamine lesion of the dopaminergic mesotelencephalic system in neonatal and adult ratsD N Abrous, J M Rivet, M Le Moal, et al.European Journal of Pharmacology|August 24, 1993
WAY 100,135 and (-)-tertatolol act as antagonists at both 5-HT1A autoreceptors and postsynaptic 5-HT1A receptors in vivoF Lejeune, J M Rivet, A Gobert, et al.Pageof 6